Injectable Opioid Agonist Treatment

Presenters: Julie Foreman, RN BSN
Hope to Health Research and Innovation Centre, BC-CfE
Dr. Christy Sutherland, MD CCFP
Medical Director, PHS Community Services Society

Share this video:
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below